EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Five-year Survival Rate of Stomach Cancer Patients in the Golestan Province, Iran

Reza Ghaffari, Sima Besharat, Gholamreza Roshandel, Amirhossein Amiriani, Hamideh Sadeghzadeh, Seyyed Mehdi Sedaghat, Taghi Amiriani

Archives of Iranian Medicine · 2026-04-01 · 29 (4) · 226-232

DOI: 10.34172/aim.37034 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Gastric cancer (GC) remains a major cause of cancer mortality worldwide, with particularly high incidence and poor survival in northeastern Iran. This study aimed to estimate the 1-, 3-, and 5-year survival rates of GC patients diagnosed in the Golestan Province in 2015–2016 and to identify demographic and clinical factors associated with survival. Methods: In this cohort study, newly diagnosed GC cases were retrieved from the Golestan Population-based Cancer Registry. Vital status was determined through registry records and telephone follow-ups. Survival rates were calculated using life table and Kaplan–Meier methods, with group comparisons made using the log-rank test. Cox proportional hazards regression assessed the association between potential risk factors and mortality. Results: Among 476 reviewed cases, 298 were included in the survival analysis. The mean age at diagnosis was 64.6±13.7 years, and 67.9% of patients were male. At follow-up, 87.6% had died. The 1-, 3-, and 5-year survival rates were 59%, 21%, and 13%, respectively. Older age ( P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →